Site search

Bacteria discreetly dwelling in throat main source of Strep A transmission News article

Breakthrough research has found that Group A Streptococcus (GAS) infections are more likely transmitted from asymptomatic throat carriage than skin-to-skin contact in communities with high rates of infection.

Metformin and atorvastatin for adults with depression Research study

The Hearts and Minds clinical trial is aiming to determine whether metformin or atorvastatin help to reduce symptoms of major depression and improve quality of life.

Medical Elective Program

The Royal Melbourne Hospital (RMH) Clinical School coordinates medical elective requests from Australian and overseas medical students in addition to teaching medical students from the University of Melbourne.

Non-emergency online and telephone services

There are online services available for non-life threatening emergencies, as well as telephone helplines available for non-urgent medical advice and mental health crisis support.

Centre for Clinical Pastoral Education

Clinical Pastoral Education is an experiential educational process set within the context of direct pastoral ministry.

Refugee Health RMH Service

We provide specialist care for immigrants, refugees and travellers with a range of conditions, including infectious diseases and nutritional deficiencies.

Prurigo Nodularis trial Research study

The Prurigo Nodularis trial aims to assess the safety and effectiveness of a treatment to assist in reducing symptoms for people living with this condition

Patients without a Medicare card

Patients who do not have a valid a Medicare card (called Medicare ineligible patients) are generally responsible for all costs associated with their treatment at the Royal Melbourne Hospital.

Treatment & vaccination for tuberculosis

Tuberculosis (TB) disease can be treated with antibiotics. Prevention can involve vaccination, screening, contact tracing and education.

Clinical trial phases

Clinical trials for medication, treatment and devices are divided into phases.

Vertigo drug trial helping patients with ‘childhood Alzheimer’s’ News article

Autumn Hodgson lives with NP-C, a rare degenerative disease.

ANAVEX®2-73 for mild cognitive impairment or early Alzheimer’s disease Research study

 A clinical trial that aims to assess the safety and efficacy of a new drug (ANAVEX®2-73) for the treatment of early Alzheimer’s disease.

New $33 million Intensive Care Unit opens for critically ill Victorians News article

Victoria’s first comprehensive Intensive Care Unit (ICU) serving three major Melbourne hospitals has opened at the Royal Melbourne Hospital.

Respiratory lab and tests

We provide general respiratory services to patients, including respiratory function assessment, fibreoptic bronchoscopy, sleep monitoring, lung oncology and clinical management of all respiratory disorders.

Privacy and disclaimer

In accordance with Victorian legislation and Government policy, the Royal Melbourne Hospital protects the privacy of personal and health information it holds. This Privacy Statement explains how your personal information (being information capable of identifying you as an individual) will be...

Barzolvolimab in patients with Chronic Spontaneous Urticaria Research study

This clinical trial seeks to assess the safety and effectiveness of Barzolvolimab in participants with Chronic Spontaneous Urticaria (CSU) who remain symptomatic despite use of antihistamine treatment. 

Advanced Interventions in Mood Disorders Clinic

The Advanced Interventions in Mood Disorders (AIM) Clinic provides adults with severe mood disorders access to novel treatments and innovative research projects.

Consumer and carer lived experience workforce

We value the expertise that lived experience brings to our mental health services and are committed to improving our consumer and carer workforce.

Our hospital renovation works continue News article

If you’re heading to the RMH Parkville this week, things may look a little different while we renovate our site. Our improvement works have closed certain areas, which may change the path you need to take to get to your floor or ward.

Geographic atrophy from age-related macular degeneration Research study

The Golden trial is a study of a potential new treatment referred to as ISIS 696844 to determine its safety and effectiveness in slowing the progression of geographic atrophy (GA) caused by age-related macular degeneration (AMD).